Siemens Healthineers · 6 hours ago
Head of Enterprise Strategy
Siemens Healthineers is a leader in medical technology, dedicated to pioneering breakthroughs in healthcare. The Head of Enterprise Strategy will lead long-range planning and strategic direction across the Varian portfolio, collaborating with global business leaders to align strategies with organizational goals.
Health CareHealth DiagnosticsMedicalMedical Device
Responsibilities
You will lead the annual and multi-year strategic planning cycle, setting the foundation for the organization’s strategic vision
You will manage portfolio prioritization, resource allocation, and investment governance to optimize enterprise performance
You will develop strategic deliverables for the Executive Leadership Team (ELT), CEO, and Management Board (MB)
You will build insights that guide market, competitive, and clinical direction, anticipating industry shifts and policy changes
You will drive cross-business line strategy alignment and prioritization, ensuring short-term actions connect to long-term value
You will build and maintain enterprise dashboards and KPI scorecards to monitor progress and outcomes
You will oversee strategy governance forums and maintain the enterprise operating rhythm
You will coordinate Key Opinion Leader (KOL) meetings with business leads to inform strategic decisions
Qualification
Required
10–15+ years of progressive experience in strategy, corporate development, enterprise planning, or portfolio management within MedTech, Oncology, Healthcare Technology, or related sectors
Demonstrated leadership experience overseeing enterprise or business unit strategies in a complex, matrixed global organization
Deep familiarity with the oncology ecosystem, including radiation therapy, clinical workflows, precision medicine, or health tech innovation
Experience with AI-driven healthcare solutions, digital ecosystems, clinical decision support, or data-enabled product strategies
Proven track record strategic planning cycles
Ability to travel up to 25%
Strategic Leadership in enterprise planning, portfolio governance, and cross-functional alignment within MedTech, Oncology, Healthcare AI, or related high-tech sectors
Ability to translate complex concepts into actionable strategies
Deep understanding of oncology ecosystems, clinical workflows, and digital/AI innovation trends shaping the future of radiation therapy
Strong analytical proficiency in market intelligence, competitive landscape assessment, financial modeling, forecasting, and KPI development
Experience influencing and partnering with senior executives, including preparation of materials for ELT, CEO, and Board audiences
Excellence in executive communication and strategic storytelling, with the ability to simplify complexity for decision-makers
Demonstrated capability leading strategy governance, operating rhythms, and enterprise-wide prioritization processes
Skilled in driving transformation, building alignment across matrixed global teams, and reducing initiative redundancy
Preferred
Advance degree, preferably in Business Administration (MBA), Health Economics, Healthcare Administration, Biomedical Engineering, Data Science, or related field preferred
PhD or equivalent in a clinical, technical, or scientific domain is a plus
Benefits
Medical insurance
Dental insurance
Vision insurance
401(k) retirement plan
Life insurance
Long-term and short-term disability insurance
Paid parking/public transportation
Paid time off
Paid sick and safe time
Company
Siemens Healthineers
Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services. It is a sub-organization of Siemens.
H1B Sponsorship
Siemens Healthineers has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (104)
2024 (70)
2023 (64)
2022 (89)
2021 (50)
2020 (86)
Funding
Current Stage
Public CompanyTotal Funding
$2.76BKey Investors
Ontario Together Fund
2021-05-25Grant· $2.5M
2021-03-25Post Ipo Equity· $2.76B
2018-03-16IPO
Leadership Team
Recent News
2026-01-21
Company data provided by crunchbase